Bryn Mawr Capital Management LLC Sells 1,918 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

Bryn Mawr Capital Management LLC lowered its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 19.1% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,147 shares of the medical research company's stock after selling 1,918 shares during the quarter. Bryn Mawr Capital Management LLC's holdings in Thermo Fisher Scientific were worth $4,054,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Bernard Wealth Management Corp. bought a new position in Thermo Fisher Scientific in the 4th quarter worth approximately $25,000. Ameriflex Group Inc. acquired a new stake in shares of Thermo Fisher Scientific in the 4th quarter valued at $30,000. Cassady Schiller Wealth Management LLC lifted its stake in shares of Thermo Fisher Scientific by 89.2% during the fourth quarter. Cassady Schiller Wealth Management LLC now owns 70 shares of the medical research company's stock valued at $36,000 after acquiring an additional 33 shares during the period. VSM Wealth Advisory LLC bought a new position in Thermo Fisher Scientific in the fourth quarter valued at about $36,000. Finally, Navigoe LLC bought a new stake in Thermo Fisher Scientific during the 4th quarter worth about $37,000. Institutional investors and hedge funds own 89.23% of the company's stock.

Insider Activity at Thermo Fisher Scientific

In other Thermo Fisher Scientific news, EVP Gianluca Pettiti sold 300 shares of Thermo Fisher Scientific stock in a transaction on Monday, April 28th. The shares were sold at an average price of $429.93, for a total value of $128,979.00. Following the sale, the executive vice president directly owned 23,167 shares in the company, valued at approximately $9,960,188.31. The trade was a 1.28% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have recently issued reports on TMO shares. The Goldman Sachs Group set a $610.00 target price on shares of Thermo Fisher Scientific and gave the company a "buy" rating in a research note on Wednesday, April 23rd. Scotiabank raised shares of Thermo Fisher Scientific from a "sector perform" rating to a "sector outperform" rating and set a $590.00 target price for the company in a report on Friday, July 11th. UBS Group downgraded Thermo Fisher Scientific from a "buy" rating to a "neutral" rating and cut their price target for the company from $500.00 to $460.00 in a research note on Tuesday, July 8th. Evercore ISI dropped their price objective on Thermo Fisher Scientific from $500.00 to $480.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. Finally, Argus reduced their target price on Thermo Fisher Scientific from $620.00 to $470.00 and set a "buy" rating on the stock in a report on Tuesday, April 29th. Four research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company's stock. According to MarketBeat.com, Thermo Fisher Scientific has an average rating of "Moderate Buy" and a consensus target price of $600.30.

Thermo Fisher Scientific Stock Down 0.4%

Shares of TMO stock traded down $1.58 during trading hours on Wednesday, hitting $416.42. 2,762,254 shares of the company were exchanged, compared to its average volume of 2,012,529. The company has a market capitalization of $157.19 billion, a PE ratio of 24.42, a PEG ratio of 2.22 and a beta of 0.77. Thermo Fisher Scientific Inc. has a 52 week low of $385.46 and a 52 week high of $627.88. The business has a 50 day moving average of $409.84 and a two-hundred day moving average of $474.37. The company has a current ratio of 1.77, a quick ratio of 1.38 and a debt-to-equity ratio of 0.64.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The medical research company reported $5.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.10 by $0.05. The firm had revenue of $10.36 billion for the quarter, compared to the consensus estimate of $10.23 billion. Thermo Fisher Scientific had a return on equity of 17.15% and a net margin of 15.19%. The company's revenue for the quarter was up .2% on a year-over-year basis. During the same quarter last year, the business posted $5.11 EPS. Analysts anticipate that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year.

Thermo Fisher Scientific Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Monday, September 15th will be paid a dividend of $0.43 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $1.72 annualized dividend and a dividend yield of 0.41%. Thermo Fisher Scientific's dividend payout ratio is currently 10.09%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.